Ebola virus (EBOV) is a negative-sense RNA virus that can infect humans and nonhuman
primates with severe health consequences. Development of countermeasures requires a …

The latest Ebola virus (EBOV) epidemic spread rapidly through Guinea, Sierra Leone, and
Liberia, creating a global public health crisis and accelerating the assessment of …

A glimpse into immune responses evolving against Ebola virus | Nature Medicine Skip to main
content Thank you for visiting nature.com. You are using a browser version with limited support …

Ebola virus (EBOV) is one of the most virulent pathogens to humans. Recently, the largest-
ever outbreak of Ebola virus disease (EVD) in West Africa, 2013–2016, resulted in the …

Evolution of antibody repertoire against the Ebola virus (EBOV) proteome was characterized
in an acutely infected patient receiving supportive care alone to elucidate virus-host …

This study addresses the role of Ebola virus (EBOV) specific infectivity in virulence.
Filoviruses are highly lethal, enveloped, single-stranded negative-sense RNA viruses that …

Five species of Ebola virus (EBOV) have been identified, with nucleotide differences of 30–
45% between species. Four of these species have been shown to cause Ebola hemorrhagic …

The still ongoing Ebola outbreak in West Africa, which began in 2013, and with more than
27,000 cases and 11,000 deaths so far, highlights the need for a vaccine against the …

Introduction Ebola virus (EBOV) is an RNA virus of the Filoviridae family that is responsible
for outbreaks of hemorrhagic fevers in primates with a lethality rate as high as 90%. EBOV …

Purpose The Ebola outbreak of 2013–2016 severely affected West Africa and resulted in
2544 deaths and 1270 survivors in Guinea, the country where it began. This Ebola virus was …